Title : Rifaximin in nonalcoholic fatty liver disease: hit multiple targets with a single shot.

Pub. Date : 2018 Oct

PMID : 30096092






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 After 6 months of rifaximin therapy, patients with NASH showed a significant reduction in homeostatic model assessment, alanine aminotransferase, aspartate aminotransferase, gamma-glutamyl transferase, endotoxin, toll-like receptor-4, IL-6, tumor necrosis factor-alpha, CK-18, and NAFLD-liver fat score (all P<0.05), but no changes in the lipid profile; moreover, there was a mild nonstatistically significant reduction of BMI. Rifaximin interleukin 6 Homo sapiens